Core Viewpoint - The company intends to use part of the excess raised funds to permanently supplement its working capital, which aligns with its operational needs and benefits all shareholders [1][3][5]. Group 1: Fundraising Overview - The total amount raised from the initial public offering (IPO) was RMB 879.25 million, with a net amount of RMB 784.01 million after deducting issuance costs [1]. - The excess funds amounted to RMB 405.24 million, which is approximately 46% of the total raised funds [1][3]. Group 2: Investment Project Details - The total investment amount for the projects funded by the raised capital is RMB 378.77 million, which will be fully covered by the raised funds [2]. Group 3: Previous Use of Excess Funds - In a previous decision, the company approved the use of RMB 120 million from the excess funds to permanently supplement working capital, representing 29.61% of the total excess funds [2][3]. Group 4: Current Plan for Excess Funds - The company plans to use RMB 120 million from the excess funds for working capital, maintaining that this will not affect the normal implementation of the fundraising investment projects [3][5]. - The cumulative use of excess funds for working capital will not exceed 30% of the total excess funds within a twelve-month period [5]. Group 5: Impact on Operations and Commitments - The use of excess funds for working capital is intended to enhance operational efficiency and reduce financial costs, ultimately improving profitability without impacting the investment projects [3][5]. - The company commits to not engaging in high-risk investments or providing financial assistance to entities outside of its controlling subsidiaries within twelve months after the use of excess funds [5]. Group 6: Review and Approval Process - The board of directors and the audit committee have reviewed and approved the use of excess funds, confirming compliance with relevant laws and regulations [5][6]. - The proposal will be submitted for approval at the upcoming shareholders' meeting [5].

证券代码：688623 证券简称：双元科技 公告编号：2025-031 浙江双元科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 ? 浙江双元科技股份有限公司（以下简称"公司"）于 2025 年 8 月 25 日 召开了第二届董事会第八次会议、第二届监事会第六次会议，审议通过了《关于 使用部分超募资金永久补充流动资金的议案》，同意公司使用部分超募资金 为 29.96%。 公司募集资金净额为 166,635.87 万元，募集资金投资项目计划使用募集资金 月 30 日募集资金使用情况如下： 单位：人民币万元 截至 2025 年 6 月 募集资金 募集资金承诺 募集资金投资项目 30 日募集资金累 投资计划 投资总额 计投入金额 智 能 测控 装 备 生 产基 地 项目 研发中心项目 14,815.13 14,815.13 3,521.59 营 销 网络 及 技 术 支持 中 心建设项目 补充流动资金 14,000.00 14,000.00 14,000.00 超募资金 101,478.09 101,478.09 ...

华林证券股份有限公司 关于四川君逸数码科技股份有限公司 使用部分超募资金永久补充流动资金事项的核查意见 华林证券股份有限公司（以下简称"华林证券"或"保荐机构"）作为四川 君逸数码科技股份有限公司（以下简称"君逸数码"或"公司"）首次公开发行 经中国证券监督管理委员会《关于同意四川君逸数码科技股份有限公司首次 公开发行股票注册的批复》（证监许可〔2023〕1232 号）同意注册，公司首次 公开发行人民币普通股（A 股）股票 3,080.00 万股，发行价格为人民币 31.33 元 /股，募集资金总额为人民币 96,496.40 万元，扣除各项发行费用（不含税）人民 币 8,683.93 万元后，募集资金净额为人民币 87,812.47 万元。上述募集资金已于 专户"），经信永中和会计师事务所（特殊普通合伙）审验，并出具 XYZH/2023CDAA1B0394 号《验资报告》。 公司于 2024 年 10 月 23 日召开第四届董事会第三次会议和第四届监事会第 三次会议，审议通过了《关于募集资金投资项目延期并增加实施主体及募集资金 专户的议案》，同意募集资金投资项目"地下综合管廊智慧管理运营平台升级建 设项目" ...

关于浙江双元科技股份有限公司 使用部分超募资金永久补充流动资金的核查意见 民生证券股份有限公司（以下简称"民生证券"或"保荐机构"）作为浙江双 元科技股份有限公司（以下简称"公司"或"双元科技"）首次公开发行股票并在 科创板上市的募集资金持续督导机构，根据《证券发行上市保荐业务管理办法》 《上市公司募集资金监管规则》《上海证券交易所科创板股票上市规则》《上 海证券交易所科创板上市公司自律监管指引第1号——规范运作》等有关规定， 对公司拟使用部分超募资金永久补充流动资金的事项进行了核查，核查情况及 核查意见如下： 一、募集资金基本情况 民生证券股份有限公司 根据中国证券监督管理委员会（以下简称"中国证监会"）于2023年4月17 日签发的《关于同意浙江双元科技股份有限公司首次公开发行股票注册的批复》 （证监许可〔2023〕803号）。公司获准向社会公开发行人民币普通股（A股） 股票1,478.57万股，每股面值1元，每股发行价格为人民币125.88元，募集资金 总额为人民币186,122.39万元，扣除发行费用人民币19,486.52万元，实际募集资 金净额为166,635.87万元，上述募集资金已于2023年 ...

中信建投证券股份有限公司 关于金凯（辽宁）生命科技股份有限公司 使用部分超募资金永久补充流动资金的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"保荐人"）为 金凯（辽宁）生命科技股份有限公司（以下简称"金凯生科"、"公司"）首次 公开发行股票并在创业板上市的保荐人及持续督导机构，根据《证券发行上市保 荐业务管理办法》《上市公司募集资金监管规则》《深圳证券交易所创业板股票 上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司 规范运作》等法规的有关规定，对金凯生科使用部分超募资金永久补充流动资金 事项进行了审慎核查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2023 年 5 月 注册的批复》（证监许可〔2023〕1115 号），金凯生科首次向社会公开发行人民 币普通股（A 股）21,508,335.00 股，发行价格为 56.56 元/股，本次发行募集资金 总额为 1,216,511,427.60 元，扣除发行费用 105,767,121.02 元后，募集资金净额 为 1,110,744,306.58 元。募集资金已于 ...

Core Viewpoint - Tianfeng Securities has conducted a special review regarding Guangdong Jushi Chemical Co., Ltd.'s return of raised funds and the use of remaining over-raised funds for permanent working capital supplementation, confirming compliance with relevant regulations and the interests of the company and its shareholders [1][7]. Summary by Sections 1. Basic Situation of Raised Funds - Guangdong Jushi Chemical was approved to publicly issue 23,333,334 shares at a price of RMB 36.65 per share, raising a total of RMB 855.1667 million, with a net amount of RMB 775.7297 million after deducting issuance costs of RMB 79.4370 million [1][2]. 2. Return of Temporarily Used Funds - The company temporarily used up to RMB 90 million of idle raised funds for working capital, which was approved by the board and returned to the special account by the date of the review [2][6]. 3. Investment Project Overview - The total investment amount for the projects funded by the raised funds is RMB 490.4617 million, with the net amount of raised funds being RMB 775.7297 million, resulting in a total over-raised amount of RMB 285.2680 million [2][4]. 4. Use of Over-raised Funds - The company plans to use RMB 43.5844 million of the remaining over-raised funds for permanent working capital, which accounts for 15.28% of the total over-raised funds [5][6]. 5. Compliance and Commitments - The company commits that the cumulative use of over-raised funds for permanent working capital will not exceed 30% of the total over-raised funds within any twelve-month period, ensuring that this will not affect the funding needs of investment projects [6][7]. 6. Review Procedures - The proposal for using the remaining over-raised funds for permanent working capital has been approved by the board and is pending submission to the shareholders' meeting for further approval [6][8]. 7. Sponsor's Review Opinion - Tianfeng Securities has no objections to the company's plan to use remaining over-raised funds for permanent working capital, confirming that the necessary review procedures have been followed and that there is no change in the purpose of the raised funds [7][8].

Group 1 - The board of directors of Guangdong Jushi Chemical Co., Ltd. held its second meeting of the seventh session on August 18, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1][2][3] - The board approved the proposal to use remaining raised funds totaling 43.5838 million RMB for permanent working capital, which accounts for 15.28% of the total raised funds [1][2] - The board also approved a special report on the use of previously raised funds, which was verified by Zhongxinghua Accounting Firm [2] - A proposal for the third extraordinary shareholders' meeting scheduled for September 3, 2025, was also approved [2][3]

格隆汇8月18日丨聚石化学(688669.SH)公布，2025年8月18日，公司召开第七届董事会第二次会议审议 通过了《关于使用剩余超募资金永久补充流动资金的议案》，同意公司使用剩余超募资金总计4,358.38 万元人民币用于永久补充流动资金。本次拟用于永久补充流动资金的超募资金占超募资金总额的 15.28%。 ...

Core Viewpoint - The company, Maolai Optical, has made significant decisions regarding its financial management and operational strategies, including the use of idle funds for wealth management and the initiation of foreign exchange hedging activities. Group 1: Stock Performance - As of August 15, 2025, Maolai Optical's stock closed at 353.44 yuan, reflecting a 5.66% increase from the previous week's closing price of 334.52 yuan [1] - The stock reached a weekly high of 361.99 yuan on August 14 and a low of 321.28 yuan on August 12 [1] - The company's current total market capitalization is 18.662 billion yuan, ranking 12th out of 92 in the optical and optoelectronic sector and 973rd out of 5,152 in the A-share market [1] Group 2: Board and Supervisory Decisions - The fourth board of directors held its 13th meeting on August 13, 2025, where several key resolutions were passed, including the use of idle funds for wealth management and the initiation of foreign exchange hedging transactions [1][2] - The supervisory board also convened on the same day, approving similar resolutions regarding the use of idle funds and foreign exchange hedging, emphasizing the benefits of these actions for the company's financial stability [2] - A notice was issued for the second extraordinary shareholders' meeting of 2025, scheduled for September 12, 2025, to discuss the use of excess funds and the reappointment of the auditing firm [2] Group 3: Financial Management Initiatives - The company plans to use up to 100 million yuan of its idle funds for wealth management, focusing on low-risk, high-liquidity investment products [3] - A proposal was made to use 12.3 million yuan of excess funds to permanently supplement working capital, which constitutes 29.90% of the total excess funds [5] - The company intends to engage in foreign exchange hedging transactions with a limit of 100 million yuan, using its own funds and not involving speculative activities [3]

Core Viewpoint - The company plans to use CNY 35 million of its excess raised funds to permanently supplement its working capital, which accounts for 29.73% of the total excess funds raised [1][3][4]. Fundraising Overview - The company successfully raised a total of CNY 510 million through its initial public offering (IPO), issuing 17 million shares at CNY 30 per share, with a net amount of CNY 458.57 million after deducting issuance costs of CNY 51.43 million [1][2]. - The total investment amount for the projects funded by the raised capital is CNY 340.84 million, leaving an excess of CNY 117.73 million after accounting for project needs [2][3]. Use of Excess Funds - As of June 30, 2025, the company has utilized CNY 35 million of the excess funds for permanent working capital, leaving a balance of CNY 83.74 million [3][4]. - The decision to use part of the excess funds for working capital is aimed at improving operational efficiency and reducing financial costs while ensuring that the original fundraising projects remain unaffected [3][5]. Approval Process - The proposal to use excess funds for working capital has been approved by the Audit Committee and the Board of Directors, confirming that it does not conflict with the implementation of the fundraising projects [5][6]. - The proposal is pending approval from the shareholders' meeting before implementation [6].